Cormorant Asset Management, LP Nektar Therapeutics Transaction History

Cormorant Asset Management, LP

$1.43 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $330,400 - $408,000	-20,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $331,200 - $509,200	-20,000 Reduced 50.0%	20,000 $400,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $157,700 - $190,300	-10,000 Reduced 20.0%	40,000 $680,000
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $1.24 Million - $1.86 Million	-75,000 Reduced 60.0%	50,000 $830,000
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $421,500 - $586,000	-25,000 Reduced 16.67%	125,000 $2.9 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $723,500 - $1.4 Million	-50,000 Reduced 25.0%	150,000 $2.68 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $9.34 Million - $13.6 Million	-588,800 Reduced 74.65%	200,000 $4.32 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $6.57 Million - $14.1 Million	388,800 Added 97.2%	788,800 $14.4 Million
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $3.1 Million - $3.63 Million	-100,000 Reduced 20.0%	400,000 $14.2 Million
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $1.48 Million - $2.18 Million	-47,000 Reduced 8.59%	500,000 $16.8 Million
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $25 Million - $46.6 Million	-823,000 Reduced 60.07%	547,000 $18 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $6.04 Million - $8.9 Million	-130,000 Reduced 8.67%	1,370,000 $83.5 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $49.2 Million - $111 Million	-1,063,200 Reduced 41.48%	1,500,000 $73.2 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $32.5 Million - $61.3 Million	565,500 Added 28.31%	2,563,200 $272 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $46 Million - $121 Million	1,997,700	1,997,700 $119 Million

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

140M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$13.4 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$12.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$11 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$7.9 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$7.73 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $157M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account